Literature DB >> 21558364

Opening up data at the European Medicines Agency.

Peter C Gøtzsche, Anders W Jørgensen.   

Abstract

Mesh：

Year:  2011        PMID： 21558364     DOI： 10.1136/bmj.d2686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  37 in total

1.  North American regulatory agencies can and should make clinical trial data publicly available.

Authors:  Nav Persaud; Peter Doshi
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

2.  Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA.

Authors:  Robert Eriksson; Lise Aagaard; Lars Juhl Jensen; Liza Borisova; Dorte Hørlück; Søren Brunak; Ebba Holme Hansen
Journal:  Pharmacol Res Perspect       Date:  2014-04-22

3.  Secrecy or transparency? The future of regulatory trial data.

Authors:  Beate Wieseler; Natalie McGauran
Journal:  CMAJ       Date:  2016-11-14       Impact factor: 8.262

4.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

5.  The potential value of discordant studies.

Authors:  Mark Doyle
Journal:  Cardiovasc Diagn Ther       Date:  2014-02

6.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

7.  Learning from hackers: open-source clinical trials.

Authors:  Adam G Dunn; Richard O Day; Kenneth D Mandl; Enrico Coiera
Journal:  Sci Transl Med       Date:  2012-05-02       Impact factor: 17.956

Review 8.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

9.  Redactions in protocols for drug trials: what industry sponsors concealed.

Authors:  Mikkel Marquardsen; Michelle Ogden; Peter C Gøtzsche
Journal:  J R Soc Med       Date:  2018-01-25       Impact factor: 5.344

Review 10.  Publication bias, with a focus on psychiatry: causes and solutions.

Authors:  Erick H Turner
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.